What does Affinity Asset Advisors, LLC hold? Q1 2026 13F Holdings & Portfolio

AI Analysis · Q1 2026 · Q1 2026

Affinity Asset Advisors, LLC filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight

STATE STR SPDR S&P 500 ETF T

$130M200K6.7%

APOGEE THERAPEUTICS INC

$108M1.3M5.6%

XENON PHARMACEUTICALS INC

$97M1.7M5.0%

ERASCA INC

$87M5.3M4.5%

INSMED INC

$78M480K4.1%

ROIVANT SCIENCES LTD

$78M2.8M4.0%

SPYRE THERAPEUTICS INC

$65M1.3M3.3%

CENTESSA PHARMACEUTICALS PLC

$56M1.4M2.9%

PRAXIS PRECISION MEDICINES I

$55M170K2.8%

ANAPTYSBIO INC

$52M940K2.7%

Filing history loading…